Midostaurin
![Midostaurin Structure](CAS/GIF/120685-11-2.gif)
- CAS No.
- 120685-11-2
- Chemical Name:
- Midostaurin
- Synonyms
- QTH113;CS-730;PKC412A;PKC 412A;PKC-412A;CGP 41231;Cgp 41251;Cgp-41251;Cgp 41 251;midostaruin
- CBNumber:
- CB71315281
- Molecular Formula:
- C35H30N4O4
- Molecular Weight:
- 570.64
- MOL File:
- 120685-11-2.mol
- Modify Date:
- 2024/5/23 14:47:35
Melting point | 235-260℃ |
---|---|
Density | 1.47±0.1 g/cm3(Predicted) |
storage temp. | Sealed in dry,Store in freezer, under -20°C |
solubility | Soluble in DMSO (15 mg/ml), MDC (10 mg/ml), methanol (5 mg/ml), 100% ethanol (2.5 mg/ml), and DMF (20 mg/ml). |
pka | 14.19±0.70(Predicted) |
form | Tan solid |
color | White |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 2 months. |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS08 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H360FD | |||||||||
Precautionary statements | P201-P202-P280-P308+P313-P405-P501 | |||||||||
Hazard Codes | T | |||||||||
Risk Statements | 36/37/38 | |||||||||
HS Code | 29329990 | |||||||||
NFPA 704 |
|
Midostaurin price More Price(1)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | 539648 | Staurosporine, N-Benzoyl A cell-permeable Staurosporine derivative that displays antitumor properties. | 120685-11-2 | 1MG | ₹21460 | 2022-06-14 | Buy |
Product number | Packaging | Price | Buy |
---|---|---|---|
539648 | 1MG | ₹21460 | Buy |
Midostaurin Chemical Properties,Uses,Production
Definition
ChEBI: An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.
brand name
Rydapt
General Description
Class: receptor tyrosine kinase; Treatment: AML, SM; Other name: PKC-412, CGP41251; Elimination half-life = 20 h; Protein binding > 99%
Biological Activity
Broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms ( α , β , γ ), PDFR β , VEGFR2, Syk, PKCη, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
target
Primary targets: FLT3, KIT
Midostaurin Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 227)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
Dr. Reddy's Laboratories Ltd | +91-4049002900 +91-4049002900 | Hyderabad, India | 165 | 58 | Inquiry |
Apicore Pharmaceuticals Pvt Ltd | +91-2662267177 +91-2662267166 | Gujarat, India | 181 | 58 | Inquiry |
AKASH PHARMA EXPORTS | +91-9388123451 +91-9846039283 | Kerela, India | 470 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
CONCORD BIOTECH LTD | +91 79 68138700 | New Delhi, India | 18 | 58 | Inquiry |
DR REDDYS LABORATORIES LTD | +91-40-49002900 | New Delhi, India | 201 | 58 | Inquiry |
120685-11-2(Midostaurin)Related Search:
Benzamide, N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-hydroxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-
3 Hydroxy Midostaurin Epimer 2 (CGP52421 Epimer 2)
3 Hydroxy Midostaurin Epimer 1 (CGP52421 Epimer 1)
Epothilone D
Ibrutinib
chevron_left
1of3
chevron_right
CGP 41251MIDOSTAURIN(PKC412)
N-((5S,6R,7R,9R)-6-Methoxy-14-oxo-5,6,7,8,9,14,15,16-octahydro-17-oxa-4b,9a,15-triaza-5,9-Methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-MethylbenzaMide
PKC-412, CGP-41251
Midostaurin (PKC412)
PKC412 (Midostaurin)
CGP 41231
N-Benzoylstaurosporine
(Midostaurin) Benzoylstaurosporine
midostaruin
4'-N-benzoylstaurosporine
Midostaurin, Benzoylstaurosporine, 4'-N-Benzoylstaurosporine, CGP 41251
Benzamide, N-((9S,10R,11R,13R)-2,3,9,10,11,12-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-J)(1,7)benzodiazonin-11-yl)-N-methyl-
Benzamide, N-(2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-1-oxo-8,12-epoxy-1H,8H-2,7B,12A-triazadibenzo(A,G)cyclonona(cde)trinden-10-yl)-N-methyl-, (8alpha,9beta,10beta,12alpha)-
Benzoylstaurosporine
Cgp 41 251
Cgp 41251
Cgp-41251
Midostaurin
Midostaurin [inn]
[9S-(9α,10β,11β,13α)]-N-(2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl)-N-methylbenzamide
PKC412 CGP 41231 CGP 41251 Midostaurin Benzoylstaurosporine
Benzamide, N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-
Midostaurin USP/EP/BP
Midaustorin
N-((5S,6R,7R,9S)-6-Methoxy-5-methyl-14-oxo-5,6,7,8,9,14,15,16-octahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide
PKC412(Midostaurin,CGP41231,CGP41251)
PKC412 from Staurosporine
QTH113
Staurosporine, N-Benzoyl
MIDOSTAURIN; CGP-41251; PKC-412; PKC412;PKC 412
CS-730
MIDOSTAURIN (PKC412; CGP 41251)
Midoridoline
N-((5S,6R,7R,9R)-6-Methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide
Midostaurin (Amorphous and Form II)
N-((5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-5,6,7,8,9,14,15,16-octahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide
PKC 412A
PKC412A
PKC-412A
Midostaurin Impurity
120685-11-2
20685-11-2
C35H30N4O4
C325H30N4O4
antibiotic
Pharmaceutical